Related references
Note: Only part of the references are listed.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
High fat diet induced obesity is mitigated in Cyp3a-null female mice
Ramiya Kumar et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver
Rohitash Jamwal et al.
MOLECULAR PHARMACEUTICS (2018)
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Chang-Hai Liu et al.
JOURNAL OF HEPATOLOGY (2018)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cells
Liang Yan et al.
PHARMACOGENOMICS (2017)
Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs
Babu Swathy et al.
EPIGENOMICS (2017)
Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues
Sarah Maximos et al.
PHARMACEUTICS (2017)
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria (vol 24, pg 1259, 2017)
Zhijun Guo et al.
CELL CHEMICAL BIOLOGY (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Manoela Mota et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis
Fatjon Leti et al.
TRANSLATIONAL RESEARCH (2015)
CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease
Sarah J. Woolsey et al.
DRUG METABOLISM AND DISPOSITION (2015)
Increased Levels of Fatty Acids Contributed to Induction of Hepatic CYP3A4 Activity Induced by Diabetes - In Vitro Evidence From HepG2 Cell and Fa2N-4 Cell Lines
Nan Hu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Lipotoxic Effect of p21 on Free Fatty Acid-Induced Steatosis in L02 Cells
Jie-wei Wang et al.
PLOS ONE (2014)
Non-alcoholic fatty liver disease
Naveed Sattar et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease
Anna Alisi et al.
LABORATORY INVESTIGATION (2011)
Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice
Igor P. Pogribny et al.
LABORATORY INVESTIGATION (2010)
Cytochrome P450 and Steatosis
Maria Jose Gomez-Lechon et al.
CURRENT DRUG METABOLISM (2009)
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
Matteo Ricchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
Yu-Zhuo Pan et al.
DRUG METABOLISM AND DISPOSITION (2009)
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
Craig D. Fisher et al.
DRUG METABOLISM AND DISPOSITION (2009)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
Post-transcriptional regulation of human pregnane x receptor by micro-RNA affects the expression of cytochrome P450 3A4
Shingo Takagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
Nora Anderson et al.
PHARMACOLOGICAL REVIEWS (2008)
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Harmeet Malhi et al.
SEMINARS IN LIVER DISEASE (2008)
Cytochrome P450 3A polymorphisms and immunosuppressive drugs:: an update
Dany Anglicheau et al.
PHARMACOGENOMICS (2007)
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity
Dhanashri Kolwankar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts
M. Teresa Donato et al.
DRUG METABOLISM AND DISPOSITION (2006)
Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet
Kouichi Yoshinari et al.
PHARMACEUTICAL RESEARCH (2006)
Clinical implications of CYP3A polymorphisms
Leszek Wojnowski et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis
D Wang et al.
ENDOCRINOLOGY (2006)
MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence
V Rusinov et al.
NUCLEIC ACIDS RESEARCH (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
AE Feldstein et al.
HEPATOLOGY (2004)
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
AE Feldstein et al.
JOURNAL OF HEPATOLOGY (2003)
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis
G Musso et al.
HEPATOLOGY (2003)
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis
V Nehra et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Share Paper
